Vaccine News and Research

Latest Vaccine News and Research

Safety established for Vaxin's first flu vaccine in clinical trial

Vaxin Inc., a privately-held biotechnology company, has demonstrated, in a Phase I human clinical study, that the company's recombinant influenza vaccine provides a potential alternative to traditional flu vaccines.

12 Jan 2005

Novel vaccine that uses immune cells as factories to produce Her2/neu protein may offer a way to treat some breast cancers

Based on successful animal studies, a novel vaccine that uses immune cells as factories to produce Her2/neu protein may offer a way to treat some human breast cancers, say researchers at The University of Texas M. D. Anderson Cancer Center.

10 Jan 2005

Key genetic factor determines HIV/AIDS risk

People with more copies of a gene that helps to fight HIV are less likely to become infected with the virus or to develop AIDS than those of the same geographical ancestry, such as European Americans, who have fewer copies of the gene, according to a study funded by the National Institute of Allergy and Infectious Diseases (NIAID).

10 Jan 2005

Australia attempts to develop treatments against Hendra virus and Nipah virus

With funding from the United States' National Institutes of Health (NIH), and in collaboration with a research team led by Dr Christopher Broder at the Uniformed Services University of the Health Sciences in Bethesda Maryland, CSIRO Livestock Industries' Australian Animal Health Laboratory (AAHL) in Geelong is attempting to develop treatments against Hendra virus and Nipah virus.

9 Jan 2005

FDA clearance to test influenza vaccine, Fluviral

ID Biomedical Corporation announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to begin immediate clinical testing of its influenza vaccine, Fluviral, in the United States under an Investigational New Drug application (IND).

7 Jan 2005

Discovery could lead to a screening test that identifies people who have a higher or lower susceptibility to HIV/AIDS

6 Jan 2005

DermaVir, a novel treatment for HIV/AIDS, complements and improves present drug therapies

DermaVir, a novel treatment for HIV/AIDS, offers a new option which complements and improves present drug therapies. The vaccine, applied topically to the skin, has demonstrated efficacy in boosting immune responses and controlling virus replication in chronically infected monkeys.

6 Jan 2005

AIDS breakthrough - vaccine strengthens the body’s immune system againts HIV

A Hadassah University Medical Center research team has developed a vaccine that significantly strengthens the body’s immune system against the autoimmune sequela of HIV infection, a breakthrough that could dramatically make an impact in the treatment of AIDS patients.

28 Dec 2004

Course of injections in childhood might help protect people from heart disease later in life

A course of injections in childhood might help protect people from heart disease later in life. And for those whose arteries are already clogged up, a dose of antibodies could provide immediate benefits. That's the enticing vision raised by animal studies.

26 Dec 2004

Shape of a protein on the surface of pneumonia bacteria helps germs invade the human bloodstream

Scientists at St. Jude Children's Research Hospital have discovered that the shape of a protein on the surface of pneumonia bacteria helps these germs invade the human bloodstream.

23 Dec 2004

Vaccine Treatment and Evaluation Units (VTEUs) supply the nurse power necessary to beat back or altogether prevent infectious disease

Flu. Smallpox. Anthrax. Whooping cough. The words represent a veritable murderers' row of infectious agents whose death toll runs in the millions.

23 Dec 2004

Researchers can now inexpensively program the chemical synthesis of entire genes on a single microchip

Devices the size of a pager now have greater capabilities than computers that once occupied an entire room. Similar advances are being made in the emerging field of synthetic biology at the University of Houston, now allowing researchers to inexpensively program the chemical synthesis of entire genes on a single microchip.

23 Dec 2004

Gulf War report confirms link between lung cancer and combustion products

The available evidence is too sparse or of insufficient quality to determine whether the majority of health problems that may be experienced by Gulf War veterans could be associated with exposures to fuels for military vehicles, propellents in Scud missiles, or substances given off by combustion sources such as oil-well fires, exhausts, and tent heaters

21 Dec 2004

Theory that could help to cure diseases including cancer

An Open University science student has astonished the world of medicine with a theory that could help to cure diseases including cancer.

21 Dec 2004

New compound Viprovex could save millions

The World Health Organization (WHO) and influenza experts worldwide are concerned that the recent appearance and widespread distribution of an avian influenza virus (Influenza A/H5N1) has the potential to ignite the next pandemic and potentially kill millions.

21 Dec 2004

20 new policies adopted by American Public Health Association

The American Public Health Association recently adopted 20 policies addressing a broad range of issues in public health from underage alcohol consumption and nutrition labeling in restaurants to the supply of flu vaccinations and threats to immigrants’ health care.

21 Dec 2004

Vaccine against cervical cancer

Dutch researcher Laura Bungener has developed a vaccine against cervical cancer. Vaccinated laboratory animals no longer developed the disease and animals which had already developed a tumour, could be treated with the vaccine.

20 Dec 2004

Study models impact of anthrax vaccine

Rapidly distributing antibiotics to people exposed to anthrax spores during a bioterrorist attack, could by itself, prevent about 70 percent of anthrax infections from occurring, according to researchers from the Johns Hopkins Bloomberg School of Public Health.

16 Dec 2004

Key advance in understanding the proteins and mechanisms involved in the spread of Lyme Disease

Virginia Commonwealth University scientists have made a key advance in understanding the proteins and mechanisms involved in the spread of Lyme Disease, a finding that could lead to a vaccine against the tick-borne illness that affects thousands of people each year.

16 Dec 2004

Landmark campaign, intends to help one million children under-five fight measles, polio and malaria

In the first nationwide campaign of its kind, Togo’s children will receive four life-saving interventions at once. The landmark campaign, launched today, intends to reach one million children under-five with vaccines to prevent measles and polio, mosquito nets to prevent malaria and deworming tablets.

14 Dec 2004

Vaccine News and Research

Latest Vaccine News and Research

Safety established for Vaxin's first flu vaccine in clinical trial

Novel vaccine that uses immune cells as factories to produce Her2/neu protein may offer a way to treat some breast cancers

Key genetic factor determines HIV/AIDS risk

Australia attempts to develop treatments against Hendra virus and Nipah virus

FDA clearance to test influenza vaccine, Fluviral

Discovery could lead to a screening test that identifies people who have a higher or lower susceptibility to HIV/AIDS

DermaVir, a novel treatment for HIV/AIDS, complements and improves present drug therapies

AIDS breakthrough - vaccine strengthens the body’s immune system againts HIV

Course of injections in childhood might help protect people from heart disease later in life

Shape of a protein on the surface of pneumonia bacteria helps germs invade the human bloodstream

Vaccine Treatment and Evaluation Units (VTEUs) supply the nurse power necessary to beat back or altogether prevent infectious disease

Researchers can now inexpensively program the chemical synthesis of entire genes on a single microchip

Gulf War report confirms link between lung cancer and combustion products

Theory that could help to cure diseases including cancer

New compound Viprovex could save millions

20 new policies adopted by American Public Health Association

Vaccine against cervical cancer

Study models impact of anthrax vaccine

Key advance in understanding the proteins and mechanisms involved in the spread of Lyme Disease

Landmark campaign, intends to help one million children under-five fight measles, polio and malaria

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Vaccine News and Research

Latest Vaccine News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in